Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| piperacillin-tazobactam (antibiotic)s - Escherichia coli O15:H11 |
👶
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases (BMC Infect Dis ) Vol: 17 Issue 1 Pages: 776 Pub: 2017 Dec 18 Epub: 2017 Dec 18 Authors Zhang H , Yang Q , Liao K , Ni Y , Yu Y , Hu B , Sun Z , Huang W , Wang Y , Wu A , Feng X , Luo Y , Chu Y , Chen S , Cao B , Su J , Duan Q , Zhang S , Shao H , Kong H , Gui B , Hu Z , Badal R , Xu Y , Html Article Publication |
| piperacillin-tazobactam (antibiotic)s - Escherichia coli O15:H11 |
👶
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Annals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob ) Vol: 3 Issue Pages: 14 Pub: 2004 Jul 29 Epub: 2004 Jul 29 Authors Jones ME , Draghi DC , Thornsberry C , Karlowsky JA , Sahm DF , Wenzel RP , Html Article Publication |
| piperacillin-tazobactam (antibiotic)s - Escherichia coli O15:H11 |
👶
Phenotypic and Molecular Characterization of Extended-Spectrum ß-Lactamase Produced by Escherichia coli, and Klebsiella pneumoniae Isolates in an Educational Hospital. Jundishapur journal of microbiology (Jundishapur J Microbiol ) Vol: 7 Issue 10 Pages: e11758 Pub: 2014 Oct Epub: 2014 Oct 1 Authors Gholipour A , Soleimani N , Shokri D , Mobasherizadeh S , Kardi M , Baradaran A , Html Article Publication |
| piperacillin-tazobactam (antibiotic)s - Escherichia coli O15:H11 |
👶
Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. African health sciences (Afr Health Sci ) Vol: 6 Issue 4 Pages: 232-5 Pub: 2006 Dec Epub: Authors Gangoue-Pieboji J , Koulla-Shiro S , Ngassam P , Adiogo D , Ndumbe P , Html Article Publication |
| piperacillin-tazobactam (antibiotic)s - Escherichia coli O15:H11 |
👶
Unravelling the collateral damage of antibiotics on gut bacteria. Nature (Nature ) Vol: 599 Issue 7883 Pages: 120-124 Pub: 2021 Nov Epub: 2021 Oct 13 Authors Maier L , Goemans CV , Wirbel J , Kuhn M , Eberl C , Pruteanu M , Müller P , Garcia-Santamarina S , Cacace E , Zhang B , Gekeler C , Banerjee T , Anderson EE , Milanese A , Löber U , Forslund SK , Patil KR , Zimmermann M , Stecher B , Zeller G , Bork P , Typas A , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.